Case Study: Pfizer acquires Amplyx Pharmaceuticals
Posted on28 Apr 2021
Tagsacquisition, acquisition in pharma, Fosmanogepix, pfizer, Pfizer's Acquisition of Anacor, pharma deal, Why Pfizer to acquire AM Pharma
Comments0
Pfizer has bought privately held Amplyx Pharmaceuticals for an undisclosed sum, gaining experimental antifungal and antiviral treatments as the world’s attention turns... Read More
Insight on why Jazz Pharmaceuticals to acquire GW Pharma?
GW Pharmaceuticals announced they have entered into an agreement with Jazz Pharmaceutical. As per the agreement, Jazz to acquire GW Pharma. Both... Read More
Sanofi-kymab-deal: Sanofi’s acquisition of a clinical-stage biopharmaceutical company Kymab
Global pharmaceutical company, Sanofi will acquire a clinical-stage biopahrmaceutical company Kymab. Sanofi will acquire Kymab for an upfront payment of approximately $1.1... Read More
Myovant and Pfizer’s $4.2 Billion Deal for Orgovyx
Myovant Sciences is partnering with Pfizer to develop and commercialize Orgovyx for prostate cancer and women’s health. Orgovyx is the brand of... Read More
Telix Pharma to acquire TheraPharm GmbH
Telix Pharmaceuticals announced that it has entered into an agreement with Scintec Diagnostics GmbH (Scintec) to acquire TheraPharm GmbH, a Swiss-German biotechnology... Read More
Covid 19 Vaccine development and commercialization status | More than 50 vaccine candidate under development
Posted on28 Nov 2020
Comments0
More than 50 covid-19 vaccine candidate is currently under development. Here you can have the close look into the development status of... Read More
PostEra codevelopment deal with NeuroLucent for Alzheimer’s disease
Posted on28 Nov 2020
Comments0
Biotechnology company PostEra announced a collaboration with NeuroLucent, a Chicago-based company focused on developing novel treatments for Alzheimer’s disease and other dementias.... Read More
AbbVie, Eisai received new indication approval for Humira to treat pyoderma gangrenosum
AbbVie GK and Eisai Co, Ltd announced an approval of additional indication of Humira, a fully human anti-TNFa monoclonal antibody, for the... Read More
Pfizer submitted application for emergency use of Covid vaccine
US drugmaker Pfizer Inc, which has developed a vaccine against coronavirus, is now seeking the emergency use tag from the US government... Read More
Insight on VFMCRP, Fresenius Kabi distribution agreement for Veltassa to treat hyperkalemia in China
Posted on20 Nov 2020
Comments0
Vifor Fresenius Medical Care Renal Pharma (VFMCRP) and Fresenius Kabi announced an agreement to develop, register and distribute Veltassa for the treatment... Read More